( A and B ) Intracellular cAMP accumulation measured by enzymatic immunoassay in lysates from ( A ) caSMCs and ( B ) mouse and human caECs treated for 10 minutes with 100 nM each of GLP-1(2836), scrambled control, IPE, forskolin, or PBS control ( n = 3/treatment, each in triplicate)
As a result, over the long-term, semaglutide was projected to be a dominant treatment compared with placebo
In the time since Congress began debating various PBM reforms, certain PBM business practices may have evolved in ways that could blunt the potential spending impact of these efforts, unless those new practices are also specifically targeted
Diabetes Care 43 , 487493 (2020)
Whilst these guidelines do not explicitly reference GLP-1 agonists, following current guidance on best practice would lead to their use being documented and taken into account in interpreting the appearance of an individual patients FDG PET-CT scan. Misinterpreting the patterns in scans as detected in this study could nevertheless lead to unnecessary investigations, inappropriate cancer staging (determining the size of a tumor and its activity) and delays in treatment, the researchers have warned
